POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes

COPD is a complex and heterogeneous disease characterized by chronic airway inflammation.1 The latter may alter airway antimicrobial defense systems and therefore favor the colonization of the bronchial mucosa by potentially pathogenic microorganisms (PPM).2 The most frequent PPMs that are capable of provoking clinical symptoms or that have impact in the COPD prognosis are listed here: Haemophilus influenza and parainfluenza, Streptococcus pneumoniae, Moraxella Catarrhalis, Pseudomonas aeruginosa, Staphylococcus aureus and some enterobacteriaceae. These PPMs, and more importantly, the presence of chronic bronchial infection (CBI), which is defined as the repeated isolation of PPMs from the airway overtime, could be a potential mechanism of disease progression and poor health outcomes in patients with COPD.3
Puedes leer el artículo completo aquí: https://journal.chestnet.org/article/S0012-3692(22)01251-X/fulltext
Noticias relacionadas

Clinical characteristics of chronic obstructive pulmonary disease in never-smokers: A systematic review
Chronic Obstructive Pulmonary Disease (COPD) is the third cause of death worldwide. While tobacco smoking is a key risk factor, COPD also occurs in never-smokers (NS).

XXXV Jornadas Técnicas del Institut Guttmann
El 21 de junio se celebrará en CaixaFòrum Barcelona las XXXV Jornadas Técnicas del Institut Guttmann. Este año las jornadas están dedicadas a la humanización en la asistencia, con el foco en la neurorrehabilitación

ERJ Podcast: GOLD 2023
Chief Editor James Chalmers interviews Alvar Agusti (Hospital Clinic, Barcelona, Spain)about the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) report. Listen it here.
Más artículos
COPD
- 769799·Alvar Agusti, Peter G. Gibson, Vanessa M. McDonald. Treatable Traits in Airway Disease: From Theory to Practice
- 769874·Bartolome R Celli et Al. Differential Diagnosis of Suspected COPD Exacerbations in the Acute Care Setting: Best Practice
- 778791·Alvar Agusti et Al. COPD: Providing the right treatment for the right patient at the right time
- 778987·Àlvar Agustí et al. Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study
- 779376·Gerard J. Criner, Alvar Agusti, Hossein Borghaei, Joseph Friedberg, Fernando J. Martinez, Curtis Miyamoto, Claus F. Vogelmeier, Bartolome R. Celli.Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en Canva Pro el 18 de mayo de 2023.